Want to see IN:JLHL full AI Analyst Report?
JLHL Stock Chart & Stats
₹328.25
₹0.90(0.28%)
At close: 4:00 PM EDT
₹328.25
₹0.90(0.28%)
Day’s Range― - ―
52-Week Range₹230.41 - ₹337.90
Previous CloseN/A
Volume280.64K
Average Volume (3M)947.00
Market Cap
₹108.22B
Enterprise Value₹83.85K
Total Cash (Recent Filing)₹5.64B
Total Debt (Recent Filing)₹4.03B
Price to Earnings (P/E)58.0
Beta0.15
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.06%
Share Statistics
EPS (TTM)6.06
Shares Outstanding327,830,100
10 Day Avg. Volume721
30 Day Avg. Volume947
Financial Highlights & Ratios
PEG Ratio98.12
Price to Book (P/B)5.45
Price to Sales (P/S)5.61
P/FCF Ratio-35.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.49
Revenue Forecast (FY)₹18.11B
Bulls Say, Bears Say
Bulls Say
Consistent Multi-year Revenue GrowthSustained top-line scaling over multiple years indicates durable demand for hospital services and expanding market penetration. Reliable revenue growth supports higher capacity utilization, funds reinvestment in facilities and specialists, and underpins longer-term margin recovery and strategic expansion.
Turnaround To Sustained ProfitabilityA move from loss-making to consistent net profitability reflects improved operating execution and pricing/clinical mix. Sustainable profits strengthen internal funding for capex, support retained earnings growth and ROE, and reduce reliance on external capital over a multi-quarter horizon.
Marked Improvement In Leverage ProfileA materially improved debt-to-equity profile increases financial flexibility and lowers refinancing and interest-rate vulnerability. Stronger equity cushions support expansion and absorb shocks, enabling steadier investment in facilities and specialties with lower solvency risk over coming quarters.
Bears Say
Sharply Negative Free Cash Flow (2025–2026)Persistent negative free cash flow after reinvestment signals heavy capex or working-capital absorption that reduces cash available for debt reduction, dividends, or strategic investments. If this persists, the company may need external funding or to curb growth, pressuring long-term financial flexibility.
Margin Compression In 2026 Versus 2025Declining margins across gross, EBIT and net lines suggest rising costs, unfavorable service mix, or ramp-related expenses. Structural margin pressure would erode return on invested capital and reduce cash conversion from revenues, lowering resilience to cyclical or competitive shocks.
Step-up In Total Debt In 2026An increase in total debt after prior deleveraging can reverse improvements in leverage and raise interest burdens. Continued debt accumulation would limit strategic optionality, increase refinancing risk, and could strain liquidity if free cash flow remains negative.
Jupiter Life Line Hospitals Ltd. News
JLHL FAQ
What was Jupiter Life Line Hospitals Ltd.’s price range in the past 12 months?
Jupiter Life Line Hospitals Ltd. lowest stock price was ₹230.41 and its highest was ₹337.90 in the past 12 months.
What is Jupiter Life Line Hospitals Ltd.’s market cap?
Jupiter Life Line Hospitals Ltd.’s market cap is ₹108.22B.
When is Jupiter Life Line Hospitals Ltd.’s upcoming earnings report date?
Jupiter Life Line Hospitals Ltd.’s upcoming earnings report date is Nov 06, 2026 which is in 93 days.
How were Jupiter Life Line Hospitals Ltd.’s earnings last quarter?
Jupiter Life Line Hospitals Ltd. released its earnings results on Jul 31, 2026. The company reported ₹1.14 earnings per share for the quarter, missing the consensus estimate of ₹1.6 by -₹0.46.
Is Jupiter Life Line Hospitals Ltd. overvalued?
According to Wall Street analysts Jupiter Life Line Hospitals Ltd.’s price is currently Overvalued.
Does Jupiter Life Line Hospitals Ltd. pay dividends?
Jupiter Life Line Hospitals Ltd. pays a Annually dividend of ₹0.2 which represents an annual dividend yield of 0.06%. See more information on Jupiter Life Line Hospitals Ltd. dividends here
What is Jupiter Life Line Hospitals Ltd.’s EPS estimate?
Jupiter Life Line Hospitals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jupiter Life Line Hospitals Ltd. have?
Jupiter Life Line Hospitals Ltd. has 327,830,100 shares outstanding.
What happened to Jupiter Life Line Hospitals Ltd.’s price movement after its last earnings report?
Jupiter Life Line Hospitals Ltd. reported an EPS of ₹1.14 in its last earnings report, missing expectations of ₹1.6. Following the earnings report the stock price went down -0.662%.
Which hedge fund is a major shareholder of Jupiter Life Line Hospitals Ltd.?
Currently, no hedge funds are holding shares in IN:JLHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Jupiter Life Line Hospitals Ltd.
Jupiter Life Line Hospitals Limited, established in Mumbai, India, in 2002, operates as a multi-specialty healthcare provider throughout the country under its Jupiter brand. The company delivers a comprehensive range of medical and surgical services spanning numerous disciplines. These include diverse surgical fields such as bariatric, cardiac, general, minimal access, HPB, surgical gastroenterology, neurosurgery, organ transplant, orthopedics (including robotic knee replacement), and plastic and cosmetic surgery. Additionally, Jupiter Life Line Hospitals offers specialized care in cardiology, chest medicine, dental care, dermatology, ENT, endocrinology and diabetes, gastroenterology, hematology and bone marrow transplantation, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, nutrition and dietetics, obstetrics and gynecology, oncology, ophthalmology, pediatrics, pain management, rehabilitation, and rheumatology. Beyond its healthcare operations, the company also manages the Fortune Park Lake City Hotel located in Thane.
Technical Analysis
Artemis Medicare Services Ltd.
―
HealthCare Global Enterprises Ltd.
―
Indraprastha Medical Corporation Limited
―
Shalby Ltd.
―
Yatharth Hospital and Trauma Care Services Limited
―